Growth Evaluation In Infants With Neonatal Cholestasis by Prado C.C. et al.













GROWTH EVALUATION IN INFANTS 
WITH NEONATAL CHOLESTASIS
Camila Carbone PRADO1, Roberto José Negrão NOGUEIRA1,
Antônio de Azevedo BARROS-FILHO1, 2, Elizete Aparecida Lomazi da COSTA-PINTO1, 2 and 
Gabriel HESSEL1, 2
This study was conducted by the 1 Department of Pediatrics and 2 Center for Investigation in Pediatrics (CIPED), School of Medical Sciences, State University of 
Campinas – UNICAMP, Campinas, SP, Brazil. 




Nutritional defi ciencies are common in infants with 
chronic hepatic diseases, especially when cholestasis is 
present and its onset occurs in the fi rst year of life(3, 4, 10, 21). The 
frequency of malnutrition is approximately 50%, particularly 
in infants with established cirrhosis(3). The pathogenesis of 
weight-height defi cit is well characterized in infants and 
includes(5, 15): 1. reduced food intake; 2. impaired digestion 
and absorption of nutrients; 3. increased caloric needs. In 
neonatal cholestasis, the liver retains substances that are 
normally excreted in the bile, reducing biliary salts excretion 
in the proximal intestine. Low intraluminal concentration 
results in malabsorption of fat-soluble vitamins and food 
lipids, especially long-chain triglycerides that are essentially 
bile-dependent for absorption(8, 14). In patients with biliary 
atresia, there is a 29% increase in energy expenditure
(16)
. 
At the time these infants underwent liver transplantation, 
undernutrition was regarded as the worst prognosis 
factor(13, 17). To our knowledge, although there are no data 
available in the literature, clinical observation has indicated 
that there are quantitative differences regarding nutritional 
status and growth defi cit for both types of neonatal cholestasis, 
intra and extrahepatic. Nutritional and growth assessment 
may prove useful in establishing adequate nutritional support 
for each group of patients. Nutritional support is often 
underestimated but it has essential value in a child with liver 
disease, since it not only improves the general condition but 
also prepares the child for a future transplant(12).
Therefore, the objective of this study was to evaluate the 
nutritional status and growth pattern in infants with intrahepatic 
cholestasis (IHC) and extrahepatic cholestasis (EHC).
ABSTRACT – Background - Chronic liver diseases in childhood often cause undernutrition and growth failure. To our knowledge, 
growth parameters in infants with neonatal cholestasis are not available. Aim - To evaluate the nutritional status and growth pattern 
in infants with intrahepatic cholestasis and extrahepatic cholestasis. Patients and methods - One hundred forty-four patients 
with neonatal cholestasis were followed up at the Pediatric Gastroenterology Service of the Teaching Hospital, State University 
of Campinas, Campinas, SP, Brazil, in a 23-year period, from 1980 to 2003. The records of these patients were reviewed and 
patients were classifi ed into two groups, according to their anatomical diagnosis: patients with intrahepatic cholestasis - group 1, 
and patients with extrahepatic cholestasis - group 2. Records of weight and height measurements were collected at 4 age stages 
of growth, in the fi rst year of life: 1) from the time of the fi rst medical visit to the age of 4 months (T1); 2) from the 5th to the 
7th month (T2); 3) from the 8th to the 10th month (T3); and 4) from the 11th to the 13th month (T4). The weight-by-age and 
height-by-age Z-scores were calculated for each patient at each stage. In order for the patient to be included in the study it was 
necessary to have the weight and/or height measurements at the 4 stages. Analyses of variance and Tukey’s tests were used for 
statistical analysis. Repeated measurement analyses of variance of the weight-by-age Z-score were performed in a 60-patient 
sample, including 29 patients from group 1 and 31 patients from group 2. The height-by-age data of 33 patients were recorded, 
15 from group 1 and 18 from group 2. Results - The mean weight-by-age Z-scores of group 1 patients at the 4 age stages were: 
T1=-1.54; T2=-1.40; T3=-0.94; T4=-0.78. There was a signifi cant difference between T2 X T3 and T1 X T4. The weight-by-age 
Z-scores for group 2 patients were :T1=-1.04; T2=-1.67; T3=-1.93 and T4=-1.77, with a signifi cant difference between T1 X T2 
and T1 X T4. The mean weight-by-age Z-scores also showed a signifi cant difference between group 1 and group 2 at stages T3 
and T4. The mean height-by-age Z-scores at the four stages in group 1 were: T1=-1.27; T2=-1.16; T3=-0.92 and T4=-0.22, with 
a signifi cant difference between T3XT4 and T1XT4. The scores for group 2 patients were: T1=-0.93; T2=-1.89; T3=-2.26 and 
T4=-2.03, with a signifi cant difference between T1XT2 and T1XT4. The mean height-by-age Z-scores also showed a signifi cant 
difference between group 1 and group 2 at T3 and T4. Conclusion - The weight and height differences between the groups became 
signifi cant from the 3rd measurement onward, with the most substantial defi cit found in the extrahepatic group. In this group, 
there is evidence that the onset of weight and height defi cit occurs between the fi rst and second evaluation stages. 
HEADINGS – Cholestasis, extrahepatic. Cholestasis, intrahepatic. Nutritional status. Anthropometry. Infant, newborn.
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PATIENTS AND METHODS
The records of all infants with intra and extrahepatic 
cholestasis assisted in the period between 1980 and 2003 were 
reviewed. Information on ponderal progression was obtained 
from the records of 60 patients (29 with IHC and 31 with EHC) 
in four periods of the 1st year of life. Among these 60 patient 
records, 33 had all of the height measurements in the same four 
periods. It was not possible to include more patients because 
of the irregularly made visits or because the patient died.
Collected data included identifi cation of cholestasis etiology 
and anthropometrical measurements. Measurements of weight and 
height were recorded in four age stages: T1 – at the fi rst medical 
visit, which occurred up to the age of 4 months; T2 – values recorded 
at a consultation that occurred between the 5th and the 7th month of 
life; T3 - values recorded at a consultation that occurred between the 
8th and the 10th month and T4 – fourth age stage values recorded at 
a consultation that occurred between the 11th and the 13th month of 
life. The weight-by-age (w/a), height-by-age (h/a) and weight for 
height (w/h) Z-scores for every patient were calculated at each age 
stage by the computer software SISCRES(11) having as references 
the National Center for Health Statistic’s curves (NCHS)(9). The 
patients received nutritional guidance regarding a normocaloric, 
low-fat diet with medium-chain triglyceride supplementation. They 
were also prescribed liposoluble vitamins (A, D and E) for oral 
intake and parenteral administration of vitamin K. The repeated 
measurement analyses of variance and Tukey’s test were used to 
explain the variability of Z-scores in relation to group and time 
factors(6). The study was previously approved by the Research 
Ethics Committee of the School of Medical Sciences – UNICAMP, 
Campinas, SP, Brazil.
RESULTS
Table 1 shows the causes of neonatal cholestasis in groups 
1 and 2. As regards IHC, the most frequent causes had an 
infectious or idiopathic origin, while the main cause for EHC 
was extrahepatic biliary duct atresia (EHBDA).
Table 2 and Figure 1 show the mean Z-score values for 
weight-by-age; Table 3 and Figure 2 show height-by-age and 
Table 4 and Figure 3 show weight-for-height indexes in groups 
1 and 2, at four stages of assessment. 
Group 1 





Metabolic disorders 2 6.9
Hypoplasia of the intrahepatic biliary ducts 2 6.9
Idiopathic 12 41.4
Group 2 
(n = 31 patients)
Nº %
Extrahepatic biliary duct atresia 28 90.3
Choledochal cyst 3 9.7
TABLE 1 –  Etiology of neonatal cholestasis in group 1 (intrahepatic cholestasis 
= IHC) and group 2 (extrahepatic cholestasis = EHC)
Cholestasis
 Intrahepatic (n=29) Extrahepatic (n=31)
Tukey
(Intra x Extra)
T1 -1.54±1.33 -1.04±0.84 P> 0.05
T2 -1.40±1.61 -1.67±1.06 P> 0.05
T3 -0.94±1.62 -1.93±1.33 P< 0.05
T4 -0.78±1.76 -1.77±1.41 P< 0.05
TABLE 2 – Comparison between age stages of Z-score for weight-by-age 
in patients of group 1 (intrahepatic cholestasis) and group 2 
(extrahepatic cholestasis)
1. ANOVA for repeated measurements: P<0.05 both for intrahepatic and for extrahepatic cholestasis
2. Tukey test:
a. Intrahepatic: T2 x T3, P = 0.0009; T1 x T4, P = 0.0036; T1 x T2 and T3 x T4, P>0.05
 b. Extrahepatic: T1 x T2, P = 0.0002; T1 x T4, P = 0.0010; T2 x T3 and T3 x T4, P>0.05
3. T1: appointment up to the 4th month of life; T2: appointment between the 5th and the 7th month; T3: appointment
Cholestasis
 Intrahepatic (n=15) Extrahepatic (n=18)
Tukey
(Intra x Extra)
T1 -1.27±1.26 -0.93±1.29 P> 0.05
T2 -1.16±1.68 -1.89±1.19 P> 0.05
T3 -0.92±1.65 -2.26±1.56 P< 0.05
T4 -0.22±1.96 -2.03±1.40 P< 0.05
TABLE 3 – Comparison between age stages of Z-score for height-by-age 
in patients of group 1 (intrahepatic cholestasis) and group 2 
(extrahepatic cholestasis)
1. ANOVA for repeated measurements: P<0.05 both for intrahepatic and for extrahepatic cholestasis
2. Tukey test:
a.Intrahepatic: T3 x T4, P = 0.0382; T1 x T4, P = 0.0390; T1 x T2 and T2 x T3, P> 0.05
b. Extrahepatic: T1 x T2, P = 0.0004; T1 x T4, P = 0.0010; T2 x T3 and T3 x T4, P> 0.05
3. T1: appointment up to the 4th month of life; T2: appointment between the 5th and the 7th month; T3: appointment




















FIGURE 1 – Evolution of the mean Z-score for weight-by-age at four 
assessment stages of patients with intrahepatic and extrahepatic 
cholestasis (the vertical bars indicate the Standard-deviations 
and are represented in a single direction)
between the 8th and the 10th month; T4: appointment between the 11th and the 13th month
between the 8th and the 10th month; T4: appointment between the 11th and the 13th month
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W/a Z-scores, which were negative in group 1, decreased over 
a period of time; the same pattern was observed in h/a Z-scores. 
On the other hand, in group 2, w/a Z-scores, which were also 
negative, increased over a period of time. The same pattern was 
observed in h/a Z-scores. 
The analysis of group and time interaction effects revealed 
signifi cant differences. No signifi cant differences were found 
between the groups at the fi rst and second age stages, but there 
were signifi cant differences at the third stage, which progressed 
into the fourth. Group 1 presented signifi cant differences 
between the values obtained at the second and third stages and 
between the values at the fi rst and fourth stages, whereas group 
2 presented signifi cant differences between the fi rst and second 
as well as between the fi rst and fourth age stages. 
The sample available for recording h/a and for analysis of 
variance included 15 patients from group 1 and 18 patients 
from Group 2. Signifi cant differences were observed regarding 
analysis of the effect of time as well as the interaction between 
group and time. Figure 2 shows an increased difference 
between the groups after the third age stage, similarly to 
w/a Z scores.
When time was compared for each group, signifi cant differences 
were observed between the third and fourth stages and between 
the fi rst and fourth stages in group 1, whereas group 2 presented 
signifi cant differences between the fi rst and second and between 
the fi rst and fourth age stages.
The statistical analysis has not shown any signifi cant difference 
between the weight/height indexes in any of the studied effects. 
DISCUSSION
This study presents the growth pattern in infants with 
neonatal cholestasis during the 1st year of life. A signifi cant 
difference was observed between the groups in relation to 
weight and height after the third age stage. The defi cit increased 
in infants with extrahepatic cholestasis. Such infants present 
normal weight at birth, not only as observed in this study but 
also reported in the literature by ALAGILLE(1). The onset of 
clinical symptoms of obstructive jaundice, choluria and fecal 
hypocholia occurred during the 1st month of life and most 
patients were 2 or 3 months old when brought for diagnostic 
investigation. The onset of cholestasis led to a reduction 
in intraluminal biliary salts, which was strongly marked in 
group 2. This reduction impaired digestion and absorption of long-
chain triglycerides (LCT) fi nally resulting in reduced utilization
(7, 19). However, at this fi rst age stage, no evidence of malnutrition 
was observed in these patients, as the Z-scores for weight and 
height were slightly higher than the Z-scores of patients in 
group 1, but with no signifi cant difference. The explanation 
for these results may be: 
1.  the birth weights of patients in group 1, which were lower than 
those in group 2, were considered close to low birth weight 
values and recovered despite the LCT digestion problem; 
2.  the patients in group 2 were potentially more prone to be affected 
concerning LCT digestion and absorption, but the consequences 
were still not evident at the time of assessment. 
FIGURE 2 – Evolution of the mean Z-score for height-by-age at four 
assessment stages of patients with intrahepatic and extrahepatic 
cholestasis (the vertical bars indicate the Standard-deviations 
and are represented in a single direction)

























T1 -0.24±0.82 -0.49 ± 1.26 P> 0.05
T2 -0.33±0.98 -0.32 ± 1.26 P> 0.05
T3 -0.22±0.83 -0.36 ± 1.11 P> 0.05
T4 -0.33±1.11 -0.23 ± 0.86 P> 0.05
TABLE 4 – Comparison between age stages of Z-score for weight-for-
height in patients of group 1 (intrahepatic cholestasis) and 
group 2 (extrahepatic cholestasis)
1. ANOVA for repeated measurements: P<0.05 both for intrahepatic and for extrahepatic cholestasis
2. Tukey test:
a. Intrahepatic: T1 x T2, T2 x T3, T3 x T4, T1 x T4, P> 0.05
b. Extrahepatic: T1 x T2, T2 x T3, T3 x T4, T1 x T4, P> 0.05
3. T1: appointment up to the 4th month of life; T2: appointment between the 5th and the 7th month; T3: appointment 
FIGURE 3 – Evolution of the mean Z-score for weight-by-height at four 
assessment stages of patients with intrahepatic and extrahepatic 
cholestasis (the vertical bars indicate the Standard-deviations 
and are represented in a single direction)

























between the 8th and the 10th month; T4: appointment between the 11th and the 13th month
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The second weight and height measurement was subsequently 
performed (between the 5th and 7th month of life). The w/a 
and h/a Z-scores showed no signifi cant difference between 
the groups. The patients in group 2 (84%) underwent surgery, 
usually during the 3rd month of life. If the catabolism present 
in this type of surgery interfered in the results of the second 
measurement, reestablishment of biliary fl ow, on the other hand, 
could promote better LCT absorption and increased caloric 
uptake. Another signifi cant result is that, although there was 
no difference between the groups, a signifi cant difference was 
observed within the EHC group between the fi rst and second 
measurements, with an expressive decline in weight and height 
Z-scores. These results can be discussed as follows: 
1.  the Kasai procedure is a major surgery that may lead to 
intense and long-lasting catabolism; 
2.  prolonged postoperative fasting is recommended, due to 
anastomosis in the jejunal segment; in most cases parenteral 
nutrition is not used; 
3.  the surgery is not entirely successful. Large studies show that 
the results are good in about 1/3 of the cases, while 2/3 of the 
patients continue with jaundice(2), which means reduced fat 
digestion. SHIGA et al.(20), conducted a study to evaluate the 
nutritional status of patients during the postoperative period 
of biliary atresia. They found that those patients whose total 
bilirubin levels were above 2 mg/100mL had smaller muscle 
area in the arms and lower prealbumin levels when compared to 
patients whose bilirubin levels were lower than 2 mg/100 mL. 
The third assessment is similar to the fourth. A signifi cant 
difference was observed between the groups regarding the w/a 
and h/a Z-scores. At this stage, the cholestatic condition in 
most infants in group 1 had been resolved and LCT digestion 
and absorption were adequate. Consequently, the w/a and 
h/a Z-scores increased. On the other hand, during the third 
assessment, patients in group 2 continued showing a decline 
in Z-scores, this stabilized at the fourth assessment. This may 
be due to the previously mentioned fact that most patients 
maintained cholestasis, as revealed by the direct increase in 
bilirubin and glutamyltransferase. Another explanation could 
be that, during this period, liver dysfunction begins in those 
cases where the Kasai surgery was partially successful or 
unsuccessful, giving rise to other conditions such as anorexia 
and increased basal metabolism that maintain a status of 
malnutrition(4, 15, 16, 18). 
An assessment of the nutritional status of patients with neonatal 
cholestasis, especially EHC carriers, is extremely important. This 
study has demonstrated that there are weight and height defi cits 
in patients with extrahepatic cholestasis and has identifi ed the 
stage in which defi cits appear. Based on these results, a rigorous 
nutritional support therapy is suggested for these patients. 
Prado CC, Nogueira RJN, Barros-Filho AA, Costa-Pinto EAL, Hessel G. Antropometria em crianças com colestase neonatal. Arq Gastroenterol. 
2006;43(4):305-9.
RESUMO – Racional - As doenças hepáticas crônicas na infância freqüentemente levam à desnutrição e ao défi cit de crescimento, sem haver 
referência de um padrão defi nido para colestase neonatal. Objetivo - Avaliar o estado nutricional e o padrão de crescimento em crianças 
com colestase intra-hepática e colestase extra-hepática. Material e métodos - Foram revistos os prontuários de 144 pacientes com colestase 
neonatal atendidos no Serviço de Gastroenterologia Pediátrica do Hospital de Clínicas da UNICAMP, Campinas, SP, durante o período 
de 1980 a 2003 e de acordo com o diagnóstico anatômico, classifi cados em dois grupos: grupo 1, pacientes com colestase intra-hepática 
e grupo 2, com colestase extra-hepática. Os valores de peso e estatura foram obtidos em quatro momentos: 1º) Na primeira consulta 
realizada até o 4º mês de vida, 2º) entre o 5º e o 7º mês, 3º) entre o 8º e o 10º mês e 4º) entre o 11º e 13º mês. Para cada paciente foi 
realizado o cálculo do Z-escore em relação ao peso para a idade e estatura para a idade nos momentos 1 a 4. Para o paciente ser incluído 
no estudo, era necessário ter as medidas de peso e/ou estatura nos quatro estágios. A estatística empregada foi a análise de variância e o 
teste de Tukey. Para análise de variância com medidas repetidas quanto ao escore-Z de peso para a idade, a amostra utilizada foi de 60 
pacientes, sendo 29 do grupo 1 e 31 do grupo 2. Para estatura, a amostra utilizada foi de 33 pacientes, sendo 15 do grupo 1 e 18 do grupo 2. 
Resultados - As médias dos escores-Z de peso para a idade nos quatro momentos da avaliação para os pacientes do grupo 1 foram: T1 =-1.54; 
T2 = -1.40; T3 = -0,94; T4 = -0.78, havendo diferença signifi cante entre T2×T3 e entre T1×T4. Para os pacientes do grupo 2 foram: T1 = -1.04; 
T2 = -1.67; T3 =-1.93 e T4 = -1.77, havendo diferença signifi cante entre T1×T2 e T1×T4. Houve também diferença signifi cante entre as 
médias dos escores-Z de peso para a idade entre o grupo 1 e o grupo 2 no T3 e no T4. As médias dos escores-Z de estatura para idade nos 
quatro momentos da avaliação para os pacientes do grupo 1 foram: T1 = -1.27; T2 = -1.16; T3 = -0.92 e T4 = -0.22, havendo diferença 
signifi cante entre T3XT4 e T1XT4. Para os pacientes do grupo 2 foram: T1 = -0.93; T2 = -1.89; T3 = -2.26 e T4 = -2.03, havendo diferença 
signifi cante entre T1×T2 e T1×T4. Houve também diferença signifi cante entre as médias dos escores-Z de estatura para a idade entre o grupo 
1 e o grupo 2 no T3 e no T4. Conclusões - As diferenças de peso e estatura entre os grupos tornaram-se signifi cantes a partir da terceira 
medida, sendo o défi cit mais acentuado no grupo extra-hepático. Nesse grupo, há evidência de que o agravo pôndero-estatural se instala 
entre o primeiro e o segundo momento de avaliação.
DESCRITORES – Colestase extra-hepática. Colestasia intra-hepática. Estado nutricional. Antropometria. Recém-nascido.
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